Article
Overexpression of primary microRNA 221/222 in acute myeloid leukemia
29 Jul 2013
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) is a hematopoietic malignancy with a dismal outcome in the majority of cases. A detailed understanding of the genetic alterations and gene expression changes that contribute to its pathogenesis is important to improve prognostication, disease monitoring, and therapy. In this context, leukemia-associated misexpression of microRNAs (miRNAs) has been studied, but no coherent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
